Insulet (PODD) Net Cash Flow (2010 - 2026)
Insulet's (PODD) quarterly Net Cash Flow came in at $55.0 million in Q2 2026, up 132.3% on a YoY basis from $23.7 million in Q2 2025, and up 123.52% quarter-over-quarter from -$233.8 million in Q1 2026.
Analysis
Insulet (PODD) Net Cash Flow (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Net Cash Flow for 17 consecutive years, with $55.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Cash Flow rose 132.3% year-over-year to $55.0 million; the trailing twelve-month figure through Jun 2026 stood at -$583.1 million (down 300.1% YoY), and the FY2025 full-year result was -$248.7 million, down 197.15% from the prior year.
- Net Cash Flow climbed to $55.0 million in Q2 2026 per PODD's latest filing, from -$233.8 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $325.9 million in Q1 2025 and bottomed at -$362.3 million in Q3 2025.
- Historically, Net Cash Flow has averaged -$15.1 million across 5 years, with a median of $17.3 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow soared 1238.89% in 2023, then tumbled 569.91% in 2025.
- Over 5 years, Net Cash Flow stood at -$52.2 million in 2022, then soared by 130.27% to $15.8 million in 2023, then jumped by 271.52% to $58.7 million in 2024, then tumbled by 171.55% to -$42.0 million in 2025, then jumped by 230.95% to $55.0 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $55.0 million, -$233.8 million, and -$42.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 746.50 Mn |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | -169.00 Mn |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 527.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -892.00 Mn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 458.40 Mn |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | -8.30 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | 55.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.00 Mn |
| Mar 31, 2026 | -233.80 Mn |
| Dec 31, 2025 | -42.00 Mn |
| Sep 30, 2025 | -362.30 Mn |
| Jun 30, 2025 | -170.30 Mn |
| Mar 31, 2025 | 325.90 Mn |
| Dec 31, 2024 | 58.70 Mn |
| Sep 30, 2024 | 77.10 Mn |
| Jun 30, 2024 | 70.70 Mn |
| Mar 31, 2024 | 49.50 Mn |
| Dec 31, 2023 | 15.80 Mn |
| Sep 30, 2023 | 26.50 Mn |
| Jun 30, 2023 | 24.10 Mn |
| Mar 31, 2023 | -53.70 Mn |
| Dec 31, 2022 | -52.20 Mn |
| Sep 30, 2022 | 18.90 Mn |
| Jun 30, 2022 | 1.80 Mn |
| Mar 31, 2022 | -80.90 Mn |
| Dec 31, 2021 | -63.40 Mn |
| Sep 30, 2021 | 4.20 Mn |